Tags: ALLWWCUR | AMINTERN | BBCHTO | BGOVBILLGO | BGOVCODES | BIZNEWS | BNALL

GW Pharma Doubles on Marijuana Drug Success in Epilepsy Trial

Monday, 14 Mar 2016 12:37 PM

(Bloomberg) -- GW Pharmaceuticals Plc surged in early U.S. trading after the drugmaker said its experimental, cannabis- based treatment for a rare form of epilepsy reduced seizures in a human trial.

The company’s American depositary receipts more than doubled to $85.50 at 8:03 a.m. in New York. Other companies with cannabis-based products also rose, including Zynerba Pharmaceuticals Inc., which gained 52 percent.

Epidiolex, a marijuana extract, reduced convulsive seizures in children with Dravet syndrome in a late-stage trial involving 120 individuals, GW said in a statement. The treatment reduced monthly convulsive seizures by 39 percent in the group receiving treatment, while a control group saw seizures fall 13 percent, GW said.

GW’s ADRs had tumbled 45 percent this year through Friday.

To contact the reporter on this story: Zachary Tracer in New York at ztracer1@bloomberg.net To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net Cecile Daurat

© Copyright 2017 Bloomberg News. All rights reserved.

   
1Like our page
2Share
Health-News
ALLWWCUR, AMINTERN, BBCHTO, BGOVBILLGO, BGOVCODES, BIZNEWS, BNALL, BNCOPY, BNCOPY2, BNSTAFF, BNTEAMS, BONDWIRES, BUSINESS, COS, DRG, EPILEPSY, EQUITYKEY, EUROPE, FINNEWS, G10MEMB, G7MEMB, GENHEA, GOWEB, HEA, HEACUR, HEACURZ2, HEATOP, HEATOPZ2, ILLNESS, INDUSTRIES, MAJOR, MARKETS, MEDMAR, MISC, MKTMISC, MOV, MSCIDVEUR, MSCINAMER, MSCIWORLD, NERVILL, NORTHAM, NYX, ONWEB, ORIGINAL, POSITIVE, READ, READ100, READ150, READ25, READ250, READ50, SENT, SPREGIONS, SRCRANK1, STFILT241, STFILT266, STK, TIMECO, TIMENI, UK, UKCURZ6, UKTOP, UKTOPZ6, US, USBNX, USCOMPNEWS, USHEALTH, WORLD, XWD
149
2016-37-14
Monday, 14 Mar 2016 12:37 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved